COVID-19 Led to an Increased Online Search Interest for “Urticaria”
Abstract
Background/Aim: Google Trends is a powerful tool for health information access and disease surveillance, including COVID-19 data forecasting. Cutaneous manifestations of COVID-19 include urticarial rash, which is multifactorial and may indicate a better prognosis. Aim of this study was to analyse the search queries for the term “urticaria” during the six years period (2017-2022) and assess the relationship between relative search volume (RSV) and a global rise in COVID-19 cases.
Methods: This study examined search queries for "urticaria" from 2017 to 2022, exploring the relationship between RSV and global COVID-19 cases. Data on "urticaria" search volume in various countries were collected using Google Trends. Microsoft Excel and correlation analysis were used to analyse the data and investigate the association between search volume and monthly COVID-19 case rise.
Results: During 2017-2019, the mean RSV for "urticaria" was 69.9 ± 10.1, which increased to 84.1 ± 8.6 during 2020-2022. The difference in means was statistically significant (p < 0.001). The mean RSV in 2022 (94.3) was the highest among all years studied. The increase in RSV from 2020 to 2022 moderately correlated (r = 0.56) with monthly COVID-19 case rise (p < 0.001). Nicaragua showed the highest search interest, while Africa, North America, Asia and Pacific, the Middle East and Europe had low search interest.
Conclusions: This study identified a significant increase in search volume for "urticaria" during the COVID-19 pandemic. Nicaragua had the highest search interest, while English-speaking countries displayed low interest. Language variation, cultural differences and COVID-19-related health concerns may influence public interest in urticaria. These findings can aid public health officials in understanding public health concerns and tailoring effective health communication strategies.
References
Nuti SV, Wayda B, Ranasinghe I, Wang S, Dreyer RP, Chen SI, Murugiah K. The use of google trends in health care research: a systematic review. PLoS One. 2014 Oct 22;9(10):e109583. doi: 10.1371/journal.pone.0109583.
Pan Z, Nguyen HL, Abu-gellban H, Zhang Y. Google Trends analysis of COVID-19 pandemic. In: 2020 IEEE International Conference on Big Data (Big Data). IEEE; 2020. 3438–46. doi: 10.1109/BigData50022.2020.9377852.
Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020 Mar 19;91(1):157-160. doi: 10.23750/abm.v91i1.9397.
Kaye AD, Cornett EM, Brondeel KC, Lerner ZI, Knight HE, Erwin A, et al. Biology of COVID-19 and related viruses: Epidemiology, signs, symptoms, diagnosis, and treatment. Best Pract Res Clin Anaesthesiol. 2021;35(3):269–92. doi: 10.1016/j.bpa.2020.12.003.
Algaadi SA. Urticaria and COVID-19: A review. Dermatol Ther. 2020 Nov;33(6):e14290. doi: 10.1111/dth.14290.
Zipursky JS, Croitoru D. Urticaria and angioedema associated with SARS-CoV-2 infection. CMAJ. 2021 Sep 7;193(35):E1390. doi: 10.1503/cmaj.211087.
Le NK, Brooks JP. Acute urticaria as the initial presentation of COVID-19 in a pediatric patient. JAAD Case Rep. 2021 May;11:137-8. doi: 10.1016/j.jdcr.2021.03.001.
Dastoli S, Bennardo L, Patruno C, Nisticò SP. Are erythema multiforme and urticaria related to a better outcome of COVID-19? Dermatol Ther. 2020 Jul;33(4):e13681. doi: 10.1111/dth.13681.
FAQ about Google Trends data - Trends Help [Internet]. 2023. Available at: https://support.google.com/trends/answer/4365533?hl=en-GB&ref_topic=6248052. [Cited: 1-Mar-2023].
ITU regions, corresponding to the regional grouping of the ITU’s Telecommunication Development Bureau [Internet]. Available at: https://www.itu.int/en/ITU-D/Statistics/Pages/definitions/regions.aspx. [Cited: 1-Mar-2023].
Choi H, Varian H. Predicting the Present with Google Trends [Internet]. Google Inc 2009. Available at: https://static.googleusercontent.com/media/www.google.com/en//googleblogs/pdfs/google_predicting_the_present.pdf. [Cited: 1-Mar-2023].
Strahan A, Ali R, Freeman EE. Chronic spontaneous urticaria after COVID-19 primary vaccine series and boosters. JAAD Case Rep. 2022 Jul;25:63-66. doi: 10.1016/j.jdcr.2022.05.012.
de Montjoye L, Herman A, Baeck M. Chronic spontaneous urticaria following COVID-19 vaccination. JAAD Case Rep. 2022 Jul;25:35-38. doi: 10.1016/j.jdcr.2022.05.011.
Muntean IA, Pintea I, Bocsan IC, Dobrican CT, Deleanu D. COVID-19 disease leading to chronic spontaneous urticaria exacerbation: a Romanian retrospective study. Healthcare (Basel). 2021 Sep 1;9(9):1144. doi: 10.3390/healthcare9091144.
Bianchi L, Hansel K, Biondi F, Napolitano M, Patruno C, Fabbrocini G, et al. Delayed urticaria after the third dose of mRNA COVID19 vaccine: A case series. Dermatol Ther. 2022 Sep;35(9):e15680. doi: 10.1111/dth.15680.
COVID-19 Cumulative Infection Collaborators. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis. Lancet. 2022 Jun 25;399(10344):2351-80. doi: 10.1016/S0140-6736(22)00484-6.
Facts and figures 2021 [Internet]. Available from: https://www.itu.int/itu-d/reports/statistics/2021/11/15/internet-use/. [Cited: 1-Mar-2023].
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).